Francisco Karkow, et al.

AHCC® in Sjögren’s Disease: One Bold Therapeutic Hypothesis

EC Microbiol. 2020; 16(1).

Zaure Zhaparkhanova, et al.

Nutritional Immunotherapy in Autoimmune Thyroid Disease: Preliminary Results

Endocrinology Quick Report. 2018; 2(50): 23-27.

Jean‑François Mallet, et al.

EC Microbiol. 2020; 16(1).

Loretta Olamigoke, et al.

Evid Based Complement Alternat Med. 2015; 2015: 508746.

Jun Takanari, et al.

J Evid Based Complementary Altern Med. 2015; 20(1): 28-34.

Mari Kogiso, et al.

Active Hexose Correlated Compound and T Cell Response in Hind – Limb – Unloaded BALB/c Mice

Int J Surg. 2015; 2(5): 32-38.

Abdelali Daddaoua, et al.

Food Chem. 2013; 136(3-4): 1288-95.

Tominori Kimura, et al.

Cell Mol Life Sci. 2013; 70(8): 1451-67.

Won-Woo Lee, et al.

Cell Immunol. 2012; 275(1-2): 19-23.

Zhinan Yin, et al.

Hum Immunol. 2010; 71(12): 1187-90.

Naoyoshi Terakawa, et al.

Nutr Cancer. 2008; 60(5): 643-51.

Katie M Love, et al.

J Trauma Acute Care Surg. 2013; 74(6): 1411-8.

Abeed H Chowdhury, et al.

Nutrients. 2019; 11(10): 2470.

Borja Ocón, et al.

Eur J Nutr. 2013; 52(2): 457-66.

Andrea Del Buono, et al.

Polysaccharide from Lentinus edodes for Integrative Cancer Treatment: Immunomodulatory Effects on Lymphocyte Population

World Cancer Research Journal. 2016; 3 (1): e652.

Zhiyun Cao, et al.

Nutr Res Pract. 2015; 9(2): 129-36.

Victoria L Gau, et al.

J Voice. 2022; 36(4): 441-442.

Judith A Smith, et al.

Front Oncol. 2022; 12: 881902.

Manami Misu, et al.

Clinical Effects of AHCC® on High-risk Human Papillomavirus Infection and Secretory IgA

Japanese Pharmacology & Therapeutics. 2019; 47(11): 1921-1928.

Judith A Smith, et al.

Front Oncol. 2019; 9: 173.

Takeshi Katsuki, et al.

COVID-19 Pathology and Countermeasures ─Necessity of Severity Prevention Self-care─

Journal of Japan Health Medicine Association, 29(2): 142-152, 2020

Ali A. Rabaan, et al.

Ann Clin Microbiol Antimicrob. 2020; 19(1): 40

Brooke E Roman, et al.

Nutr Res. 2013; 33(1): 12-7.

Shoko Nogusa, et al.

Nutr Res. 2009; 29(2): 139-43.

Beatriz López-Cauce, et al.

Biomed Pharmacother. 2022; 150: 112937.

Mireia Tena-Garitaonaindia, et al.

Front Microbiol. 2022; 13: 814448.

Barry W Ritz

Nutr Rev. 2008; 66(9): 526-31.

María-Dolores Tabar, et al.

J Vet Intern Med. 2022; 36(2): 753-757.

María Auxiliadora Dea-Ayuela, et al.

Molecules. 2020; 25(17): 3918.

Rodolfo Oliveira Leal, et al.

JFMS Open Rep. 2018; 4(2): 2055116918811374.

Sergi Segarra, et al.

Parasit Vectors. 2018; 11(1): 103.

Sergi Segarra, et al.

Vet Parasitol. 2017; 239: 50-56.

Sergi Segarra.

Microorganisms. 2021; 9(12): 2601.

John Salerno, et al.

A Pilot Open-Label Study Assessing the Effects of AHCC® Supplementation on Lyme Disease Patients

Bioactive Compounds in Health and Disease. 2019; 2(11): 221-229.

Masaki Fujita, et al.

Attenuation of Pulmonary Mycobacterium Avium Disease by Active Hexose Correlated Compound (AHCC) in Mice

J Nutr Disorders Ther. 2015; 5: 4.

Shuhui Wang, et al.

J Nutr. 2009; 139(3): 598-602.

Hernan Aviles, et al.

Am J Surg. 2008; 195(4): 537-45.

Tesfaye Belay, et al.

Infect Immun. 2021; 89(5): e00786-20.

Tesfaye Belay, et al.

J Nutr Med Diet Care. 2015; 1(1): JNMDC-1-006.

Alba Pérez-Cantero, et al.

Pharmaceutics. 2019; 11(9): 456.

Sayam Thaiudom, et al.

A study of the efficacy of Active Hexose Correlated Compound (AHCC) in the treatment of chronic Hepatitis C patients at Phramongkutklao Hospital

The Medical News (Thailand). 2010; 325: 13-16.

Hiroaki Yanagimoto, et al.

Nutr Cancer. 2023; 75(1): 236-246.

Daisuke Hashimoto, et al.

Trials. 2022; 23(1): 135.

Yasuhiro Kuramitsu, et al.

Analysis of Cancer-Related Proteins Using Electrophoresis and Its Clinical Application

Electrophoresis Letters. 2021; 65(2): 23-27.

Shajedul Islam, et al.

Oncol Lett. 2021; 22(3): 654.

Daisuke Hashimoto, et al.

Surg Today. 2021; 51(11): 1872-1876.

Anarkhuu Bold-Erdene, et al.

Clinical outcomes of active hexose correlated compound (AHCC®) and its effect on chemotherapy related adverse events in patients with unresectable pancreatic cancer

Diagnosis. 2018; 83(3): 56-60.

Keisuke Kuhara, et al.

Anticancer Res. 2018; 38(11): 6107-6111.

Hiroaki Yanagimoto, et al.

Nutr Cancer. 2016; 68(2): 234-40.

Masayuki Tokunaga, et al.

Anticancer Res. 2015; 35(11): 6063-7.

Junya Nawata, et al.

Anticancer Res. 2014; 34(9): 4807-11.

Shigeyuki Suenaga, et al.

Anticancer Res. 2014; 34(1): 141-6.

Toshiya Kamiyama, et al.

Integr Cancer Ther. 2022; 21: 15347354211073066.

Zhiyun Cao, et al.

Nutr Res Pract. 2015; 9(2): 129-36.

Koji Wakame, et al.

Long-term administration of Active Hexose Correlated Compound as a dietary supplement to a patient after breast cancer surgery and chemotherapy: A case report

Integr Cancer Sci Ther. 2017; 4(1).

Mehran Haidari, et al.

Life Sci. 2013; 93(25-26): 994-1003.

Sho Hangai, et al.

J Altern Complement Med. 2013; 19(11): 905-10.

Yoichi Matsui, et al.

Retrospective Study in Breast Cancer Patients Supplemented with AHCC

Inte J Integr Oncol. 2009; 3(2): 12-16.

Daisuke Nakamoto, et al.

Active Hexose Correlated Compound (AHCC) Alleviates Gemcitabine-Induced Hematological Toxicity in Non-Tumor-Bearing Mice

Intern J Clin Med. 2012; 3: 361-367.

Kota Shigama, et al.

J Exp Ther Oncol. 2009; 8(1): 43-51.

Buxiang Sun, et al.

Cancer Epidemiol. 2009; 33(3-4): 293-9.

Jin Young Choia, et al.

Nutr Cancer. 2018; 70(1): 109-115.

Wineeya Suknikhom, et al.

Asian Pac J Cancer Prev. 2017; 18(3): 633-638.

Yoshiteru Sumiyoshi, et al.

Jpn J Clin Oncol. 2010; 40(10): 967-72.

Jeffrey Turner, et al.

Anticancer Drugs. 2009; 20(3): 215-6.

Francesca Paganelli, et al.

Pharmaceuticals. 2021; 14(12): 1325.

Maiko Takahashi, et al.

J Clin Biochem Nutr. 2019; 65(3): 203-208.

Hong-Jai Park, et al.

Front Immunol. 2022; 13: 875872.

Reiki Ishizuka, et al.

Personalized Cancer Therapy for Stage IV Lung Cancer: Combined Use of Active Hexose Correlated Compound and Genistein Concentrated Polysaccharide

Pers Med Univers. 2012; 1(1): 39-44.

Reiki Ishizuka, et al.

Review of Cancer Therapy with AHCC(R) and GCP(R); The Long-Term Follow-Up over 12 Years for Stage IV (M1) Cancer of the Lung and the Breast

International Journal of Integrative Medicine. 2010; 2(1): 98-111.

Lata Mathew, et al.

Integr Cancer Ther. 2017; 16(3): 300-307.

Rodney J Hunter, et al.

Evaluation of active hexose correlated compound (AHCC) in combination with pegylated liposomal doxorubicin for treatment of ovarian cancer

Int J Appl Res Nat Prod. 2011; 4(3): 6-14.

Andrea Del Buono, et al.

Polysaccharide from Lentinus edodes for Integrative Cancer Treatment: Immunomodulatory Effects on Lymphocyte Population

World Cancer Research Journal. 2016; 3 (1): e652.

Yusai Kawaguchi

Improved Survival of Patients with Gastric Cancer or Colon Cancer when treated with Active Hexose Correlated Compound (AHCC): Effect of AHCC on digestive system cancer

Natural Medicine Journal. 2009; 1(1).

Kavin Fatehchand, et al.

PLoS One. 2017; 12(7): e0181729.

Dillip Kumar Parida, et al.

Integrating Complimentary and Alternative Medicine in Form of Active Hexose Correlated Compound (AHCC) in the Management of Head & Neck Cancer Patients

Intern J Clin Med. 2011; 2, 588-592.

Tamer A Badawi, et al.

Immunoprophylactic Effect of Active Hexose Correlated Compound on Normal and Induced Submandibular Salivary Gland Neoplasm in Albino Rats

Cairo Dental Journal. 2012; 28(1): 485-490.

Kavin Fatehchand, et al.

Nutr Cancer. 2014; 66(3): 377-82.

Émilie A Graham, et al.

Cancer Biol Ther. 2017; 18(10): 765-774.

Bruna Corradetti, et al.

Integr Cancer Ther. 2019; 18: 1534735419866908.

Rosa Mistica Ignacio, et al.

Cytokine. 2015; 76(2): 131-137.

Zaure Zhaparkhanova, et al.

The effect of active hexose correlated compound on (multi) nodular euthyroid goiter: A double-blind placebo-controlled study

J Clin Med Kaz. 2021; 18(2): 66-71.

Yoshito Tanaka, et al.

Nitric Oxide. 2014; 40: 75-86.

Kosuke Matsui, et al.

Eur Surg Res. 2011; 47(4): 274-83.

Tadayoshi Okumura, et al.

Inhibition of iNOS induction by functional food AHCC (Screening of food with “hepatoprotective effect” using in vitro hepatocytes)

Journal of the Japanese Society of Food Engineering. 2010; 30(3): 100-106.

Rachel E. Carlson, et al.

Screening for potential pathways of drug-supplement interactions between AHCC® and common medications

IJNF. 2018; 4(5): 32-36.

Larry W Coffer, et al.

Evaluation of active hexose correlated compound (AHCC) on phase II drug metabolism pathways and the implications for supplement-drug interactions

J Integr Oncol. 2015; doi:10.4172/2329-6771.1000142.

Claire M Mach, et al.

J Soc Integr Oncol. 2008; 6(3): 105-9.

Marie-Francoise Doursout, et al.

Int Immunopharmacol. 2016; 39: 280-286.

Cristina Mascaraque, et al.

Mol Nutr Food Res. 2014; 58(12): 2379-82.

Jun Takanari, et al.

J Evid Based Integr Med. 2018; 23: 2156587218756511.

Natalia V Mikhailichenko, et al.

An open label trial of a standardized extract of cultured Lentinula edodes mycelia (ECLM) in children with refractory epilepsy

FFHD. 2019; 9(3): 145-156.

Young-Ju Song, et al.

AHCC Supplementation Attenuates Muscle Atrophy via Akt Activation in Hindlimb-suspended Rat

Biotechnol Bioprocess Eng. 2019; 24: 476-482.

Yosuke Ueyama, et al.

J Surg Res. 2019; 243: 265-273.

Richi Nakatake, et al.

Protective effects of active hexose correlated compound in a rat model of liver injury after hepatectomy

FFHD. 2016; 6(11): 702-717.

Tetsuya Okuyama, et al.

Active Hexose Correlated Compound Extends the Lifespan and Increases the Thermotolerance of Nematodes

FFHD. 2013; 3(6):166-182.

Koji Wakame, et al.

DNA microarray analysis of gene expression changes in ICR mouse liver following treatment with active hexose correlated compound

Integr Mol Med. 2016; 3(3): 739-744.

Hyangkyoung Kim, et al.

J Nutr Sci Vitaminol. 2014; 60(5): 348-56.

Hajime Fujii, et al.

Regul Toxicol Pharmacol. 2011; 59(2): 237-50.

Takehito Miura

Unwellness and Functional Foods: The Expected Role of Pharmacies

J Jpn Mibyou Assoc. 2022; 28(2): 43-48.

Jun-Young Choi

Нэгдмэл эмчилгээ for Improvement of Quality of Life in Cancer Patients

J Korean Med Assoc. 2008; 51(5): 435-448.

Hiroshi Nishioka, et al.

J Immunol Res. 2019; 2019: 3758576

Hiroshi Nishioka, et al.

Potentiating action of AHCC on natural immunity

Medical Science Digest. 2009; 35(6): 241-244.

Philippa J Cheetham, et al.

Arch Esp Urol. 2011; 64(8): 720-34.

Francesco Di Pierro, et al.

Minerva Gastroenterol Dietol. 2020; 66(2): 172-176.

Manami Misu, et al.

Various functions of AHCC® – Case Report

New Food Industry. 2017; 59(2): 14-21.

Yutaka Horiuchi, et al.

Complementary and Alternative Medicine and AHCC®, GCP® in Companion Animals

Companion Animal Practice. 2012; 4: 53-57.

Takashi Nishizawa, et al.

Alpha Glucan (AHCC Liquid) Activates Macrophages More than Beta Glucan – Prospects for Basidiomycetes

Companion Animal Practice. 2011 Apr.

Mamoru Onuma, et al.

The supplementation therapy of caine dermatology in my hospital

Japanese Journal of Small Animal Practice. 2008; 27(6): 340-346.

Mikio Nishizawa, et al.

Assessment of anti-inflammatory effects of Japanese Kampo medicine versus functional foods

FFHD. 2019; 9(2): 79-91.

Hiroshi Nishioka, et al.

Various functions of a standardized extract of cultured Lentinula edodes mycelia (AHCC®)

Medical Science Digest. 2019; 45(2): 127-130.

Koji Wakame

Research and functional development of basidiomycete culture extracts

Agricultural biotechnology. 2017; 1(4): 438-442.

Robert M Hackman, et al.

J Am Coll Nutr. 2014; 33(4): 340-6.

Catherine Ulbricht, et al.

J Diet Suppl. 2013; 10(3): 264-308.

Yasuo Kamiyama

AHCC: basic and clinical research

Journal of the society tropical resources technologists. 2011; 27(1): 1-8.

Shinil K Shah, et al.

J Parenter Enteral Nutr. 2011; 35(4): 449-58.

Barry W Ritz

Active Hexose Correlated Compound (AHCC) and Immune Outcomes in Humans: A Review

Natural Medicine Journal. 2011; 3(1): 3-7.

Takehito Miura, et al.

Basic and Clinical Studies on Active Hexose Correlated Compound

Biotechnology in Functional Foods and Nutraceuticals. 2010: 51-58.

Takehito Miura, et al.

Basic and Clinical Studies on AHCC —Recent Topics—

Japanese Journal of Complementary and Alternative Medicine. 2009; 6(1): 1-7.

Kentaro Kitadate

Augmentation of Anticancer Activity and Attenuation of Side Effect by AHCC

FOOD Style 21. 2008; 132: 69-72.